Global and China Biosimilars Market Insights, Forecast to 2027

Global and China Biosimilars Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Biosimilars Product Introduction
1.2 Market by Type
1.2.1 Global Biosimilars Market Size Growth Rate by Type
1.2.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.3 Recombinant Glycosylated Proteins
1.3 Market by Application
1.3.1 Global Biosimilars Market Size Growth Rate by Application
1.3.2 Oncology
1.3.3 Blood Disorders
1.3.4 Growth Hormonal Deficiency
1.3.5 Chronic and Autoimmune Disorders
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biosimilars Market Size, Estimates and Forecasts
2.1.1 Global Biosimilars Revenue 2016-2027
2.1.2 Global Biosimilars Sales 2016-2027
2.2 Global Biosimilars, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Biosimilars Historical Market Size by Region (2016-2021)
2.3.1 Global Biosimilars Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Biosimilars Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Biosimilars Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Biosimilars Sales Forecast by Region (2022-2027)
2.4.2 Global Biosimilars Revenue Forecast by Region (2022-2027)
3 Global Biosimilars Competitor Landscape by Players
3.1 Global Top Biosimilars Manufacturers by Sales
3.1.1 Global Biosimilars Sales by Manufacturer (2016-2021)
3.1.2 Global Biosimilars Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Biosimilars Manufacturers by Revenue
3.2.1 Key Biosimilars Manufacturers Covered: Ranking by Revenue
3.2.2 Global Biosimilars Revenue by Manufacturers (2016-2021)
3.2.3 Global Biosimilars Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Biosimilars Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Biosimilars Revenue in 2020
3.2.6 Global Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Biosimilars Price by Manufacturers
3.4 Global Biosimilars Manufacturing Base Distribution, Product Types
3.4.1 Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biosimilars Product Type
3.4.3 Date of International Manufacturers Enter into Biosimilars Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Biosimilars Market Size by Type (2016-2021)
4.1.1 Global Biosimilars Sales by Type (2016-2021)
4.1.2 Global Biosimilars Revenue by Type (2016-2021)
4.1.3 Biosimilars Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Biosimilars Market Size Forecast by Type (2022-2027)
4.2.1 Global Biosimilars Sales Forecast by Type (2022-2027)
4.2.2 Global Biosimilars Revenue Forecast by Type (2022-2027)
4.2.3 Biosimilars Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Biosimilars Market Size by Application (2016-2021)
5.1.1 Global Biosimilars Sales by Application (2016-2021)
5.1.2 Global Biosimilars Revenue by Application (2016-2021)
5.1.3 Biosimilars Price by Application (2016-2021)
5.2 Biosimilars Market Size Forecast by Application (2022-2027)
5.2.1 Global Biosimilars Sales Forecast by Application (2022-2027)
5.2.2 Global Biosimilars Revenue Forecast by Application (2022-2027)
5.2.3 Global Biosimilars Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Biosimilars Market Size YoY Growth 2016-2027
6.1.1 China Biosimilars Sales YoY Growth 2016-2027
6.1.2 China Biosimilars Revenue YoY Growth 2016-2027
6.1.3 China Biosimilars Market Share in Global Market 2016-2027
6.2 China Biosimilars Market Size by Players (International and Local Players)
6.2.1 China Top Biosimilars Players by Sales (2016-2021)
6.2.2 China Top Biosimilars Players by Revenue (2016-2021)
6.3 China Biosimilars Historic Market Review by Type (2016-2021)
6.3.1 China Biosimilars Sales Market Share by Type (2016-2021)
6.3.2 China Biosimilars Revenue Market Share by Type (2016-2021)
6.3.3 China Biosimilars Price by Type (2016-2021)
6.4 China Biosimilars Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Biosimilars Sales Forecast by Type (2022-2027)
6.4.2 China Biosimilars Revenue Forecast by Type (2022-2027)
6.4.3 China Biosimilars Price Forecast by Type (2022-2027)
6.5 China Biosimilars Historic Market Review by Application (2016-2021)
6.5.1 China Biosimilars Sales Market Share by Application (2016-2021)
6.5.2 China Biosimilars Revenue Market Share by Application (2016-2021)
6.5.3 China Biosimilars Price by Application (2016-2021)
6.6 China Biosimilars Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Biosimilars Sales Forecast by Application (2022-2027)
6.6.2 China Biosimilars Revenue Forecast by Application (2022-2027)
6.6.3 China Biosimilars Price Forecast by Application (2022-2027)
7 North America
7.1 North America Biosimilars Market Size YoY Growth 2016-2027
7.2 North America Biosimilars Market Facts & Figures by Country
7.2.1 North America Biosimilars Sales by Country (2016-2021)
7.2.2 North America Biosimilars Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Biosimilars Market Size YoY Growth 2016-2027
8.2 Asia Pacific Biosimilars Market Facts & Figures by Region
8.2.1 Asia Pacific Biosimilars Sales by Region (2016-2021)
8.2.2 Asia Pacific Biosimilars Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Biosimilars Market Size YoY Growth 2016-2027
9.2 Europe Biosimilars Market Facts & Figures by Country
9.2.1 Europe Biosimilars Sales by Country (2016-2021)
9.2.2 Europe Biosimilars Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Biosimilars Market Size YoY Growth 2016-2027
10.2 Latin America Biosimilars Market Facts & Figures by Country
10.2.1 Latin America Biosimilars Sales by Country (2016-2021)
10.2.2 Latin America Biosimilars Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Biosimilars Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Biosimilars Market Facts & Figures by Country
11.2.1 Middle East and Africa Biosimilars Sales by Country (2016-2021)
11.2.2 Middle East and Africa Biosimilars Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Biosimilars Products Offered
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Description and Business Overview
12.2.3 Novartis Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Biosimilars Products Offered
12.2.5 Novartis Recent Development
12.3 Biocon
12.3.1 Biocon Corporation Information
12.3.2 Biocon Description and Business Overview
12.3.3 Biocon Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Biocon Biosimilars Products Offered
12.3.5 Biocon Recent Development
12.4 Biogen
12.4.1 Biogen Corporation Information
12.4.2 Biogen Description and Business Overview
12.4.3 Biogen Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Biogen Biosimilars Products Offered
12.4.5 Biogen Recent Development
12.5 Fresenius Kabi AG
12.5.1 Fresenius Kabi AG Corporation Information
12.5.2 Fresenius Kabi AG Description and Business Overview
12.5.3 Fresenius Kabi AG Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Fresenius Kabi AG Biosimilars Products Offered
12.5.5 Fresenius Kabi AG Recent Development
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Corporation Information
12.6.2 Boehringer Ingelheim Description and Business Overview
12.6.3 Boehringer Ingelheim Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Boehringer Ingelheim Biosimilars Products Offered
12.6.5 Boehringer Ingelheim Recent Development
12.7 Merck KgaA
12.7.1 Merck KgaA Corporation Information
12.7.2 Merck KgaA Description and Business Overview
12.7.3 Merck KgaA Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Merck KgaA Biosimilars Products Offered
12.7.5 Merck KgaA Recent Development
12.8 Mylan
12.8.1 Mylan Corporation Information
12.8.2 Mylan Description and Business Overview
12.8.3 Mylan Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Mylan Biosimilars Products Offered
12.8.5 Mylan Recent Development
12.9 Eli Lilly
12.9.1 Eli Lilly Corporation Information
12.9.2 Eli Lilly Description and Business Overview
12.9.3 Eli Lilly Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Eli Lilly Biosimilars Products Offered
12.9.5 Eli Lilly Recent Development
12.10 Teva Pharmaceutical
12.10.1 Teva Pharmaceutical Corporation Information
12.10.2 Teva Pharmaceutical Description and Business Overview
12.10.3 Teva Pharmaceutical Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Teva Pharmaceutical Biosimilars Products Offered
12.10.5 Teva Pharmaceutical Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Biosimilars Products Offered
12.11.5 Pfizer Recent Development
12.12 Amgen
12.12.1 Amgen Corporation Information
12.12.2 Amgen Description and Business Overview
12.12.3 Amgen Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Amgen Products Offered
12.12.5 Amgen Recent Development
12.13 Celltrion
12.13.1 Celltrion Corporation Information
12.13.2 Celltrion Description and Business Overview
12.13.3 Celltrion Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Celltrion Products Offered
12.13.5 Celltrion Recent Development
12.14 Samsung Biologics
12.14.1 Samsung Biologics Corporation Information
12.14.2 Samsung Biologics Description and Business Overview
12.14.3 Samsung Biologics Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Samsung Biologics Products Offered
12.14.5 Samsung Biologics Recent Development
12.15 Roche
12.15.1 Roche Corporation Information
12.15.2 Roche Description and Business Overview
12.15.3 Roche Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Roche Products Offered
12.15.5 Roche Recent Development
12.16 Probiomed
12.16.1 Probiomed Corporation Information
12.16.2 Probiomed Description and Business Overview
12.16.3 Probiomed Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Probiomed Products Offered
12.16.5 Probiomed Recent Development
12.17 Apotex
12.17.1 Apotex Corporation Information
12.17.2 Apotex Description and Business Overview
12.17.3 Apotex Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Apotex Products Offered
12.17.5 Apotex Recent Development
12.18 Chong Kun Dang
12.18.1 Chong Kun Dang Corporation Information
12.18.2 Chong Kun Dang Description and Business Overview
12.18.3 Chong Kun Dang Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Chong Kun Dang Products Offered
12.18.5 Chong Kun Dang Recent Development
12.19 JCR Pharmaceuticals
12.19.1 JCR Pharmaceuticals Corporation Information
12.19.2 JCR Pharmaceuticals Description and Business Overview
12.19.3 JCR Pharmaceuticals Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.19.4 JCR Pharmaceuticals Products Offered
12.19.5 JCR Pharmaceuticals Recent Development
12.20 Gan & Lee Pharmaceuticals
12.20.1 Gan & Lee Pharmaceuticals Corporation Information
12.20.2 Gan & Lee Pharmaceuticals Description and Business Overview
12.20.3 Gan & Lee Pharmaceuticals Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Gan & Lee Pharmaceuticals Products Offered
12.20.5 Gan & Lee Pharmaceuticals Recent Development
12.21 Gedeon Richter
12.21.1 Gedeon Richter Corporation Information
12.21.2 Gedeon Richter Description and Business Overview
12.21.3 Gedeon Richter Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Gedeon Richter Products Offered
12.21.5 Gedeon Richter Recent Development
12.22 Biocad
12.22.1 Biocad Corporation Information
12.22.2 Biocad Description and Business Overview
12.22.3 Biocad Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Biocad Products Offered
12.22.5 Biocad Recent Development
12.23 Coherus Bioscience
12.23.1 Coherus Bioscience Corporation Information
12.23.2 Coherus Bioscience Description and Business Overview
12.23.3 Coherus Bioscience Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Coherus Bioscience Products Offered
12.23.5 Coherus Bioscience Recent Development
12.24 Stada Arzneimittel AG
12.24.1 Stada Arzneimittel AG Corporation Information
12.24.2 Stada Arzneimittel AG Description and Business Overview
12.24.3 Stada Arzneimittel AG Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Stada Arzneimittel AG Products Offered
12.24.5 Stada Arzneimittel AG Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Biosimilars Industry Trends
13.2 Biosimilars Market Drivers
13.3 Biosimilars Market Challenges
13.4 Biosimilars Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biosimilars Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Biosimilars Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Table 3. Major Manufacturers of Recombinant Glycosylated Proteins
Table 4. Global Biosimilars Market Size Growth Rate by Application (2021-2027) & (K MT)
Table 5. Global Biosimilars Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Biosimilars Sales by Regions (2016-2021) & (K MT)
Table 7. Global Biosimilars Sales Market Share by Regions (2016-2021)
Table 8. Global Biosimilars Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Biosimilars Sales Forecast by Region (2022-2027) & (K MT)
Table 10. Global Biosimilars Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Biosimilars Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Biosimilars Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Biosimilars Sales by Manufacturers (2016-2021) (K MT)
Table 14. Global Biosimilars Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Biosimilars Manufacturers by Revenue (US$ Million) in 2020
Table 16. Biosimilars Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Biosimilars Revenue Share by Manufacturers (2016-2021)
Table 18. Global Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars as of 2020)
Table 20. Key Manufacturers Biosimilars Price (2016-2021) (USD/MT)
Table 21. Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Biosimilars Product Type
Table 23. Date of International Manufacturers Enter into Biosimilars Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Biosimilars Sales by Type (2016-2021) (K MT)
Table 26. Global Biosimilars Sales Share by Type (2016-2021)
Table 27. Global Biosimilars Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Biosimilars Revenue Share by Type (2016-2021)
Table 29. Biosimilars Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 30. Global Biosimilars Sales Forecast by Type (2022-2027) & (K MT)
Table 31. Global Biosimilars Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Biosimilars Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Biosimilars Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Biosimilars Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 35. Global Biosimilars Sales by Application (2016-2021) (K MT)
Table 36. Global Biosimilars Sales Share by Application (2016-2021)
Table 37. Global Biosimilars Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Biosimilars Revenue Share by Application (2016-2021)
Table 39. Biosimilars Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 40. Global Biosimilars Sales Forecast by Application (2022-2027) & (K MT)
Table 41. Global Biosimilars Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Biosimilars Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Biosimilars Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Biosimilars Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 45. China Biosimilars Sales (K MT) of Key Companies (2016-2021)
Table 46. China Biosimilars Sales Share by Company (2016-2021)
Table 47. China Biosimilars Revenue (US$ Million) by Company (2016-2021)
Table 48. China Biosimilars Revenue Share by Company (2016-2021)
Table 49. China Biosimilars Sales (K MT) by Type (2016-2021)
Table 50. China Biosimilars Sales Share by Type (2016-2021)
Table 51. China Biosimilars Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Biosimilars Price (USD/MT) by Type (2016-2021)
Table 53. China Biosimilars Sales (K MT) by Type (2022-2027)
Table 54. China Biosimilars Sales Share by Type (2022-2027)
Table 55. China Biosimilars Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Biosimilars Revenue Share by Type (2022-2027)
Table 57. China Biosimilars Price (USD/MT) by Type (2022-2027)
Table 58. China Biosimilars Sales (K MT) by Application (2016-2021)
Table 59. China Biosimilars Sales Share by Application (2016-2021)
Table 60. China Biosimilars Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Biosimilars Price (USD/MT) by Application (2016-2021)
Table 62. China Biosimilars Sales (K MT) by Application (2022-2027)
Table 63. China Biosimilars Sales Share by Application (2022-2027)
Table 64. China Biosimilars Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Biosimilars Revenue Share by Application (2022-2027)
Table 66. China Biosimilars Price (USD/MT) by Application (2022-2027)
Table 67. North America Biosimilars Sales by Country (2016-2021) & (K MT)
Table 68. North America Biosimilars Sales Market Share by Country (2016-2021)
Table 69. North America Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Biosimilars Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Biosimilars Sales by Region (2016-2021) & (K MT)
Table 72. Asia Pacific Biosimilars Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Biosimilars Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Biosimilars Revenue Market Share by Region (2016-2021)
Table 75. Europe Biosimilars Sales by Country (2016-2021) & (K MT)
Table 76. Europe Biosimilars Sales Market Share by Country (2016-2021)
Table 77. Europe Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Biosimilars Revenue Market Share by Country (2016-2021)
Table 79. Latin America Biosimilars Sales by Country (2016-2021) & (K MT)
Table 80. Latin America Biosimilars Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Biosimilars Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Biosimilars Sales by Country (2016-2021) & (K MT)
Table 84. Middle East and Africa Biosimilars Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Biosimilars Revenue Market Share by Country (2016-2021)
Table 87. Pfizer Corporation Information
Table 88. Pfizer Description and Business Overview
Table 89. Pfizer Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 90. Pfizer Biosimilars Product
Table 91. Pfizer Recent Development
Table 92. Novartis Corporation Information
Table 93. Novartis Description and Business Overview
Table 94. Novartis Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 95. Novartis Product
Table 96. Novartis Recent Development
Table 97. Biocon Corporation Information
Table 98. Biocon Description and Business Overview
Table 99. Biocon Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 100. Biocon Product
Table 101. Biocon Recent Development
Table 102. Biogen Corporation Information
Table 103. Biogen Description and Business Overview
Table 104. Biogen Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 105. Biogen Product
Table 106. Biogen Recent Development
Table 107. Fresenius Kabi AG Corporation Information
Table 108. Fresenius Kabi AG Description and Business Overview
Table 109. Fresenius Kabi AG Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 110. Fresenius Kabi AG Product
Table 111. Fresenius Kabi AG Recent Development
Table 112. Boehringer Ingelheim Corporation Information
Table 113. Boehringer Ingelheim Description and Business Overview
Table 114. Boehringer Ingelheim Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 115. Boehringer Ingelheim Product
Table 116. Boehringer Ingelheim Recent Development
Table 117. Merck KgaA Corporation Information
Table 118. Merck KgaA Description and Business Overview
Table 119. Merck KgaA Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 120. Merck KgaA Product
Table 121. Merck KgaA Recent Development
Table 122. Mylan Corporation Information
Table 123. Mylan Description and Business Overview
Table 124. Mylan Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 125. Mylan Product
Table 126. Mylan Recent Development
Table 127. Eli Lilly Corporation Information
Table 128. Eli Lilly Description and Business Overview
Table 129. Eli Lilly Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 130. Eli Lilly Product
Table 131. Eli Lilly Recent Development
Table 132. Teva Pharmaceutical Corporation Information
Table 133. Teva Pharmaceutical Description and Business Overview
Table 134. Teva Pharmaceutical Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 135. Teva Pharmaceutical Product
Table 136. Teva Pharmaceutical Recent Development
Table 137. Dr. Reddy's Laboratories Corporation Information
Table 138. Dr. Reddy's Laboratories Description and Business Overview
Table 139. Dr. Reddy's Laboratories Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 140. Dr. Reddy's Laboratories Product
Table 141. Dr. Reddy's Laboratories Recent Development
Table 142. Amgen Corporation Information
Table 143. Amgen Description and Business Overview
Table 144. Amgen Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 145. Amgen Product
Table 146. Amgen Recent Development
Table 147. Celltrion Corporation Information
Table 148. Celltrion Description and Business Overview
Table 149. Celltrion Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 150. Celltrion Product
Table 151. Celltrion Recent Development
Table 152. Samsung Biologics Corporation Information
Table 153. Samsung Biologics Description and Business Overview
Table 154. Samsung Biologics Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 155. Samsung Biologics Product
Table 156. Samsung Biologics Recent Development
Table 157. Roche Corporation Information
Table 158. Roche Description and Business Overview
Table 159. Roche Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 160. Roche Product
Table 161. Roche Recent Development
Table 162. Probiomed Corporation Information
Table 163. Probiomed Description and Business Overview
Table 164. Probiomed Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 165. Probiomed Product
Table 166. Probiomed Recent Development
Table 167. Apotex Corporation Information
Table 168. Apotex Description and Business Overview
Table 169. Apotex Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 170. Apotex Product
Table 171. Apotex Recent Development
Table 172. Chong Kun Dang Corporation Information
Table 173. Chong Kun Dang Description and Business Overview
Table 174. Chong Kun Dang Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 175. Chong Kun Dang Product
Table 176. Chong Kun Dang Recent Development
Table 177. JCR Pharmaceuticals Corporation Information
Table 178. JCR Pharmaceuticals Description and Business Overview
Table 179. JCR Pharmaceuticals Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 180. JCR Pharmaceuticals Product
Table 181. JCR Pharmaceuticals Recent Development
Table 182. Gan & Lee Pharmaceuticals Corporation Information
Table 183. Gan & Lee Pharmaceuticals Description and Business Overview
Table 184. Gan & Lee Pharmaceuticals Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 185. Gan & Lee Pharmaceuticals Product
Table 186. Gan & Lee Pharmaceuticals Recent Development
Table 187. Gedeon Richter Corporation Information
Table 188. Gedeon Richter Description and Business Overview
Table 189. Gedeon Richter Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 190. Gedeon Richter Product
Table 191. Gedeon Richter Recent Development
Table 192. Biocad Corporation Information
Table 193. Biocad Description and Business Overview
Table 194. Biocad Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 195. Biocad Product
Table 196. Biocad Recent Development
Table 197. Coherus Bioscience Corporation Information
Table 198. Coherus Bioscience Description and Business Overview
Table 199. Coherus Bioscience Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 200. Coherus Bioscience Product
Table 201. Coherus Bioscience Recent Development
Table 202. Stada Arzneimittel AG Corporation Information
Table 203. Stada Arzneimittel AG Description and Business Overview
Table 204. Stada Arzneimittel AG Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 205. Stada Arzneimittel AG Product
Table 206. Stada Arzneimittel AG Recent Development
Table 207. Biosimilars Market Trends
Table 208. Biosimilars Market Drivers
Table 209. Biosimilars Market Challenges
Table 210. Biosimilars Market Restraints
Table 211. Biosimilars Customers List
Table 212. Biosimilars Distributors List
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
List of Figures
Figure 1. Biosimilars Product Picture
Figure 2. Global Biosimilars Sales Market Share by Type in 2020 & 2027
Figure 3. Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Product Picture
Figure 4. Recombinant Glycosylated Proteins Product Picture
Figure 5. Global Biosimilars Sales Market Share by Application in 2020 & 2027
Figure 6. Oncology
Figure 7. Blood Disorders
Figure 8. Growth Hormonal Deficiency
Figure 9. Chronic and Autoimmune Disorders
Figure 10. Others
Figure 11. Biosimilars Report Years Considered
Figure 12. Global Biosimilars Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Biosimilars Market Size 2016-2027 (US$ Million)
Figure 14. Global Biosimilars Sales 2016-2027 (K MT)
Figure 15. Global Biosimilars Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Biosimilars Sales Market Share by Region (2016-2021)
Figure 17. Global Biosimilars Sales Market Share by Region in 2020
Figure 18. Global Biosimilars Revenue Market Share by Region (2016-2021)
Figure 19. Global Biosimilars Revenue Market Share by Region in 2020
Figure 20. Global Biosimilars Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Biosimilars Revenue in 2020
Figure 22. Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Biosimilars Sales Market Share by Type (2016-2021)
Figure 24.

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs